This is a try at UML diagrams for type 1 diabetes.



Similar documents
Beacon User Stories Version 1.0

FORWARDHEALTH PRIOR AUTHORIZATION / PREFERRED DRUG LIST (PA/PDL) FOR HYPOGLYCEMICS, INSULIN LONG-ACTING

Diabetes Self-Management Training Services

OKLAHOMA STATUTES TITLE 70. SCHOOLS DIVISION III. OTHER SCHOOL LAWS CHAPTER 15. HEALTH AND SAFETY DIABETES MANAGEMENT IN SCHOOLS ACT

Unity Point Health PROBLEM LISTS IN THE ELECTRONIC HEALTH RECORD

POLICY of 5. Students ADMINISTRATION OF MEDICATION

Diabetes Outpatient Self-Management Training (NCD 40.1)

Humulin R (U500) insulin: Prescribing Guidance

Meaningful Use of EHRs:

EHR4CR ENABLING PROACTIVE RESEARCH

School Year 20 / 20. Diabetes Health Care Plan for Southgate Schools

CHRONIC CARE MANAGEMENT TOOL KIT What Practices Need to Do to Implement and Bill CCM Codes

Blue Cross Blue Shield of Michigan Medicare Plus Blue SM and BCN Advantage SM High Intensity Care Model

Optum s Role in Mycare Ohio

Healthy Living with Diabetes. Diabetes Disease Management Program

Algorithms for Glycemic Management of Type 2 Diabetes

NOVA SCOTIA DRUG INFORMATION SYSTEM

Home Health Care Today: Higher Acuity Level of Patients Highly skilled Professionals Costeffective Uses of Technology Innovative Care Techniques

Institute of Applied Health Sciences. University of Aberdeen DATABASE REVIEW. Grampian University. Hospitals NHS Trust GRAMPIAN DIABETES

Student Name: Date of Birth:

1.00 REGULATORY AUTHORITY

Management of Clients with Diabetes Mellitus

Management of Diabetes

Sharon H. Johnson, BS, MS 123 Main Street Capital City, VA Phone:

RULES FOR STUDENT POSSESSION AND ADMINISTRATION OF ASTHMA, ALLERGY AND ANAPHYLAXIS MANAGEMENT MEDICATIONS OR OTHER PRESCRIPTION MEDICATIONS

MEDICARE ACCESS AND CHIP REAUTHORIZATION ACT (MACRA) MERIT-BASED INCENTIVE PAYMENT SYSTEM (MIPS) ADVANCING CARE INFORMATION PERFORMANCE CATEGORY

Combined Child Diabetes

SCRIPT FOR PROVIDER/ACO PHONE INQUIRIES. What is an ACO?

Student pharmacists level of confidence in providing DSME prior to entering P4 rotations

Frequently Asked Questions regarding Nurse Practitioners and Protocol Agreements

Population Health Management Program

How To Grow A Company

Exhibit 2.9 Utilization Management Program

Telephone: Home Work Cell Address Father/Guardian: Address:

MANAGEMENT OF TYPE - 1 DIABETES MELLITUS

Oregon Standards for Certified Community Behavioral Health Clinics (CCBHCs)

A State-Wide EHR for NSW Health

British Columbia Pharmacy Association (BCPhA) Clinical Service Proposal Self-Monitoring of Blood Glucose in Type 2 Diabetes

Electronic Data Solutions. E-Prescription System Software Requirement Specifications. Version 1.0

TYPE 2 DIABETES IN CHILDREN DIAGNOSIS AND THERAPY. Ines Guttmann- Bauman MD Clinical Associate Professor, Division of Pediatric Endocrinology, OHSU

PERSONNEL SPECIFICATION

The University of North Carolina Wilmington NURSE PRACTITIONER COMPETENCY PROFILE

Anneli, Martina s daughter In better control with her pump since 2011 MY CHILD HAS TYPE 1 DIABETES

INSTRUCTIONS FOR USE: OA-RX

Improving access to insulin pump therapy: The role of the Insulin Pump Network

Welcome to the Emory Diabetes Education Training Academy!

Anneli, Martina s daughter In better control with her pump since 2011 MY CHILD HAS TYPE 1 DIABETES

Insulin-Treated Diabetes. Guidelines for assessment of fitness to work as Cabin Crew

Efficacy, safety and preference study of a insulin pen PDS290 vs. a Novo Nordisk marketed insulin pen in diabetics

FHUSD Diabetic Management Plan

Split/Shared Services Documentation & Billing

Criteria: CWQI HCS-123 (This criteria is consistent with CMS guidelines for External Infusion Insulin Pumps)

THE EHR4CR PLATFORM AND SERVICES

Use Cases for Argonaut Project. Version 1.1

Frequently Asked Questions on the Medicare FQHC PPS 1

Personalized Therapy Algorithms for Type 2 Diabetes: A Phenotypization-based Approach

Treatment Approaches to Diabetes

Are insulin analogs worth their cost in type 2 diabetes?

Purdue Research Foundation

(a) Policy. Students. Draft Revised Policy. Administering Medication

Title 23: Division of Medicaid. Part 200: General Provider Information. Chapter 5: General. Rule 5.6: Diabetes Self-Management Training (DSMT)

Diabetic Ketoacidosis

Managing Diabetes in the School Setting. Alabama State Department of Education Alabama Board of Nursing

A Simplified Approach to Initiating Insulin. 4. Not meeting glycemic goals with oral hypoglycemic agents or


User guide Basal-bolus Insulin Dosing Chart: Adult

A Population Health Management Approach in the Home and Community-based Settings

My Doctor Says I Need to Take Diabetes Pills and Insulin... What Do I Do Now? BD Getting Started. Combination Therapy

Analysis and Design of a Simplified Patient Care System, DNS

Townsville NBN diabetes in-home monitoring trial Dr Karen Carlisle Townsville-Mackay Medicare Local

Home Health Initiatives Reduce Avoidable Readmissions by Leveraging Innovation

Mind the Gap: Navigating the Underground World of DKA. Objectives. Back That Train Up! 9/26/2014

Transcription:

This is a try at UML diagrams for type diabetes. Use case: These are text descriptions of a subject s experience when they enter the healthcare setting and their data is used for secondary research. Description: A healthcare provider who is affiliated with a Type Diabetes (TD) clinical research study observes the patient in the facility. The healthcare provider conducts a routine patient visit to monitor and record clinical progress, relative to TD management, in the Electronic Health Record (EHR). The data is then used to populate the Case Report Forms for the clinical research study in which the patient is already enrolled. The healthcare provider may be a physician, a nurse practitioner (NP), a physician s assistant (PA), or a research coordinator. In the use case the term clinician is used throughout. The clinician has 2 roles: healthcare provider and researcher. Actors: Patient (in patient role) Patient (in subject role) Clinician (in clinical provider role) Clinician (in research investigator role) Sponsor of the research study Goal: Develop clinical content data standards for type diabetes which support patient care and secondary data uses Trigger: Scheduled protocol visit in the clinic Pre-conditions:. A TD module exists in the EHR. This module collects complete and standardized data for the management of TD. 2. Specific elements on the TD EHR module are designated as required elements for a particular research protocol. 3. A patient record is clearly marked that the patient is enrolled in the research study of interest. Normal Path:. Patient (in subject role) arrives to clinic for a scheduled protocol visit. 2. The physician (in research investigator role) observes patient and orders required tests per research protocol. 3. Physician (in research investigator role) opens EHR to a specific TD module. 4. Physician (in research investigator role) records study data as required per protocol. 5. Physician (in clinical provider role) notes any other observations in the EHR TD module as desired as part of the clinical visit. 6. Physician (in research investigator role) selects submit research data button that is on the TD module. 7. The completed research data elements from the TD model of the EHR (already flagged as research data elements) are copied to a separate research database, held by the study sponsor. The data remain in the EHR.

8. Physician signs out of EHR/patient visit as they normally would in a clinical visit. Alternative Path: The research use of the data might occur after the health visit. The clinician will conduct a routine patient visit to monitor and record clinical progress relative to TD management in the EHR. Exceptions: The subject withdraws his/her consent from the study or dropped by the PI from the study for any reason. The clinician continues collecting data in EHR, but stops sending data to the research database. Priority: High for all users

TD Class Diagram: Diagnosis and Treatment TypeDiabetesSymptoms/ClinicalFindings + polydipsia: boolean + polyuria: boolean + polyphasia: boolean + UnexplainedWeightLoss: boolean + diabeticketoacidosis: boolean + fatigue: boolean TypeDiabetesDiagnosis + typediabetesdiagnosisdate: date + ckinicalfindings: char FamilyHistory + bloodrelativewithtd: char + bloodrelativewithautoimmunedisease: char Insulin Type + regular: char + intermediateacting: char + longacting: char GlycemiCcontrolMethod + selfmonitored: boolean + bloodtest: boolean + urinetest: boolean Commom::Patient 0 * Commom::ClinicRegistration Commom::PatietEncounter 0 * * Commom::Clinician Test + effectivedatetime: int + testdonecode: char + typecode: char BloodGlucose + casualplasmaglucose: int + fasting PlasmaGlucose: int + oralglucosetolerancetest: int + HbAc: int AutoimmuneAntibody Test + HLATyping: char + AutoimmuneThyroidDisease: char + GlutamicAcidDecarboxylaseAntibodies: char + C-peptide: int ancillarytests + ThyroidPanel: int + LipidPanel: int + BasicMetabolicPanel: int UrineTest + glucose: char + ketones char + microalbumin: char PhysicalExam + eyeexam: char + footexam: char + dentalexam: char

Table. Multiplicity Indicators. (source: http://www.agilemodeling.com/artifacts/classdiagram.htm#classes Indicator Meaning 0.. Zero or one One only Zero or more..* One or more n Only n (where n > ) 0..n Zero to n (where n > )..n One to n (where n > )